title: Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.
abstract: PRAME/MAPE/OIP4 is a germinal tissue-specific gene that is also expressed at high levels in haematological malignancies and solid tumours. The physiological functions of PRAME in normal and tumour cells are unknown, although a role in the regulation of retinoic acid signalling has been proposed. Sequence homology and structural predictions suggest that PRAME is related to the leucine-rich repeat (LRR) family of proteins, which have diverse functions. Here we review the current knowledge of the structure/function of PRAME and its relevance in leukaemia.
authors.affiliation: Gene Regulation Group, Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, UK.
authors.forename: Frances
authors.initials: F
authors.lastname: Wadelin
authors.forename: Joel
authors.initials: J
authors.lastname: Fulton
authors.forename: Paul A
authors.initials: PA
authors.lastname: McEwan
authors.forename: Keith A
authors.initials: KA
authors.lastname: Spriggs
authors.forename: Jonas
authors.initials: J
authors.lastname: Emsley
authors.forename: David M
authors.initials: DM
authors.lastname: Heery
mesh_terms: D000595:Amino Acid Sequence; D000951:Antigens, Neoplasm / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D002454:Cell Differentiation / Q000502:physiology; D049109:Cell Proliferation; D020224:Expressed Sequence Tags; D006801:Humans; D007938:Leukemia / Q000503:physiopathology*; D008969:Molecular Sequence Data; D005810:Multigene Family; D018365:Neoplasm, Residual; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D015398:Signal Transduction; D013347:Subcellular Fractions / Q000378:metabolism
chemical_list: D000951:Antigens, Neoplasm; C404944:PRAME protein, human; D018168:Receptors, Retinoic Acid
references.citation: Ann Surg Oncol. 2007 Feb;14(2):885-92
references.pmid: 17151793
references.citation: Genes Dev. 2006 Oct 1;20(19):2713-27
references.pmid: 17015433
references.citation: Clin Cancer Res. 2006 May 15;12(10):3130-6
references.pmid: 16707612
references.citation: Leuk Res. 2007 Nov;31(11):1521-8
references.pmid: 17382387
references.citation: Clin Cancer Res. 2004 Jul 1;10(13):4307-13
references.pmid: 15240516
references.citation: Annu Rev Biochem. 2007;76:447-80
references.pmid: 17328678
references.citation: Blood. 2006 Dec 15;108(13):4109-17
references.pmid: 16931630
references.citation: BMC Genomics. 2005 Sep 13;6:120
references.pmid: 16159394
references.citation: Clin Chem Lab Med. 2006;44(5):548-55
references.pmid: 16681423
references.citation: J Biol Chem. 2001 Mar 2;276(9):6695-702
references.pmid: 11078741
references.citation: Nat Protoc. 2009;4(3):363-71
references.pmid: 19247286
references.citation: Leuk Res. 2009 Mar;33(3):384-90
references.pmid: 18950857
references.citation: Blood. 2009 Mar 5;113(10):2245-55
references.pmid: 18988867
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17777-82
references.pmid: 17968018
references.citation: Leuk Res. 2006 Nov;30(11):1333-9
references.pmid: 16620968
references.citation: J Struct Biol. 2006 Aug;155(2):294-305
references.pmid: 16884925
references.citation: Breast Cancer Res Treat. 2010 Feb;119(3):593-9
references.pmid: 19291396
references.citation: Mol Microbiol. 1998 Jan;27(1):171-86
references.pmid: 9466265
references.citation: Proc Natl Acad Sci U S A. 1987 Oct;84(20):7174-8
references.pmid: 3118359
references.citation: Blood. 2009 Oct 8;114(15):3299-308
references.pmid: 19625708
references.citation: Br J Haematol. 2001 Mar;112(4):916-26
references.pmid: 11298586
references.citation: Exp Hematol. 2008 Jul;36(7):886-96
references.pmid: 18400362
references.citation: FEBS Lett. 2003 Dec 18;555(3):533-8
references.pmid: 14675769
references.citation: Leuk Res. 2009 Sep;33(9):1276-81
references.pmid: 19027161
references.citation: Cancer Genet Cytogenet. 2002 Oct 1;138(1):89-91
references.pmid: 12419593
references.citation: Nature. 1997 Jun 12;387(6634):733-6
references.pmid: 9192902
references.citation: Breast Cancer Res Treat. 2008 May;109(2):359-65
references.pmid: 17624586
references.citation: J Clin Invest. 2009 Apr;119(4):954-63
references.pmid: 19273910
references.citation: Br J Haematol. 1998 Sep;102(5):1376-9
references.pmid: 9753074
references.citation: Clin Cancer Res. 2008 Nov 15;14(22):7161-6
references.pmid: 19010831
references.citation: Head Neck. 2006 Jul;28(7):614-9
references.pmid: 16475205
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2794-9
references.pmid: 16477019
references.citation: Leuk Res. 2009 Dec;33(12):1678-83
references.pmid: 19427036
references.citation: FEBS Lett. 2000 Jan 28;466(2-3):367-71
references.pmid: 10682862
references.citation: Cell. 2005 Sep 23;122(6):835-47
references.pmid: 16179254
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6092-7
references.pmid: 15833814
references.citation: Cancer Genet Cytogenet. 2007 Aug;177(1):51-4
references.pmid: 17693191
references.citation: Ann Hematol. 2008 Oct;87(10):809-18
references.pmid: 18587578
references.citation: Leuk Res. 2010 Dec;34(12):1647-55
references.pmid: 20409582
references.citation: BMC Evol Biol. 2009 Aug 14;9:202
references.pmid: 19682372
references.citation: Nature. 1993 Dec 23-30;366(6457):751-6
references.pmid: 8264799
references.citation: Br J Cancer. 2008 Aug 5;99(3):398-403
references.pmid: 18648365
references.citation: Immunity. 1997 Feb;6(2):199-208
references.pmid: 9047241
references.citation: Eur J Immunol. 2000 Mar;30(3):803-9
references.pmid: 10741395
references.citation: Genes Chromosomes Cancer. 2007 Sep;46(9):796-804
references.pmid: 17534929
references.citation: Clin Cancer Res. 2006 Apr 15;12(8):2434-41
references.pmid: 16638849
references.citation: Haematologica. 2008 Dec;93(12):1797-805
references.pmid: 18815192
references.citation: J Biol Chem. 2003 Mar 28;278(13):10942-51
references.pmid: 12556447
references.citation: Leuk Res. 2007 Mar;31(3):365-9
references.pmid: 16914202
references.citation: Genomics. 2004 Jan;83(1):153-67
references.pmid: 14667819
references.citation: Leuk Res. 2003 May;27(5):393-6
references.pmid: 12620290
references.citation: Cancer Res. 2005 Aug 15;65(16):7348-55
references.pmid: 16103086
references.citation: J Mol Biol. 1998 Apr 3;277(3):519-27
references.pmid: 9533877
references.citation: Blood. 2009 Jul 2;114(1):148-52
references.pmid: 19398719
references.citation: Haematologica. 2006 Dec;91(12):1653-61
references.pmid: 17145602
references.citation: Int J Cancer. 2004 Feb 20;108(5):704-11
references.pmid: 14696097
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7149-53
references.pmid: 8692960
references.citation: Blood. 2008 Sep 1;112(5):1876-85
references.pmid: 18591381
references.citation: J Clin Exp Hematop. 2009 May;49(1):1-7
references.pmid: 19474511
references.citation: Eur J Cancer. 2006 Nov;42(16):2807-14
references.pmid: 16978861
references.citation: Cancer Genet Cytogenet. 2002 Mar;133(2):118-23
references.pmid: 11943337
references.citation: Cancer Immun. 2008 Feb 01;8:2
references.pmid: 18237105
references.citation: Genome Res. 2009 Oct;19(10):1905-11
references.pmid: 19549727
references.citation: Int J Cancer. 2008 Nov 1;123(9):2130-7
references.pmid: 18709641
references.citation: Oncogene. 2003 Oct 23;22(48):7687-94
references.pmid: 14576832
references.citation: Blood. 2000 Dec 15;96(13):4075-83
references.pmid: 11110676
references.citation: Blood. 2009 Mar 26;113(13):3059-69
references.pmid: 18984860
references.citation: Cancer Res. 2004 Dec 15;64(24):9167-71
references.pmid: 15604288
references.citation: Genome Res. 1997 Mar;7(3):250-61
references.pmid: 9074928